Accéder au contenu
Merck

Breast milk fatty acid composition is associated with development of atopic dermatitis in the infant.

Journal of pediatric gastroenterology and nutrition (2005-09-01)
Ulla Hoppu, Minna Rinne, Anna-Maija Lampi, Erika Isolauri
RÉSUMÉ

Breast milk fatty acids may have immunomodulatory properties related to the development of atopic disease. The aim of this study was to assess the impact of the breast milk fatty acid composition on the development of atopic dermatitis (AD) in high-risk infants. Mothers with atopic disease were recruited at the end of gestation. Maternal food records and breast milk samples were collected at the infants' age of one month. Infants were clinically examined and AD diagnosed at one, three, six, and 12 months. Altogether 13 of 34 (38%) infants were diagnosed with AD during the first year of life. Infants developing AD had consumed breast milk with a higher ratio of saturated to polyunsaturated fatty acids and less n-3 fatty acids compared to infants not developing AD. Specifically, breast milk consumed by infants with AD contained more stearic acid, 8.9% of total fatty acids (95% confidence interval 7.9-10.0) in comparison to those without AD, 7.1% (95% CI 6.6-7.7). Breast milk rich in saturated and low in n-3 fatty acids may be a risk factor for atopic dermatitis in the infant.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Acide stéarique, Grade I, ≥98.5% (capillary GC)
Sigma-Aldrich
Acide stéarique, reagent grade, 95%
Sigma-Aldrich
Acide stéarique, ≥95%, FCC, FG
Supelco
Acide stéarique, analytical standard
Supelco
Acide stéarique, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Acide stéarique, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Acide stéarique, European Pharmacopoeia (EP) Reference Standard